Drug Trial Radar · NCT05044819
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
154
Actual
Start
Jul 7, 2021
Primary completion
Aug 1, 2027
Study completion Mar 31, 2028
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- Collaborators
- Jazz Pharmaceuticals Research UK Limited
- First posted
- Sep 16, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.
Conditions
- Lennox Gastaut Syndrome
- Dravet Syndrome
- Tuberous Sclerosis Complex
Interventions
CannabidiolDrug
Oral Cannabidiol solution 100 mg/mL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Liver Fibrosis and Evaluable Fibrotic Changes as Determined and Assessed by an Independent Adjudication CommitteeTime frame: Screening, Day 365, Day 730, Day 1095, Day 1460, and Day 1825
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Clinical Trial Site
Little Rock, Arkansas
Clinical Trial Site
Downey, California
Clinical Trial Site
Long Beach, California
Clinical Trial Site
Sacramento, California
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Orlando, Florida
Clinical Trial Site
Tampa, Florida
Clinical Trial Site
Augusta, Georgia
Clinical Trial Site
Wichita, Kansas
Clinical Trial Site
Lexington, Kentucky
Clinical Trial Site
Baltimore, Maryland
Clinical Trial Site
Boston, Massachusetts
Clinical Trial Site
New Brunswick, New Jersey
Clinical Trial Site
New York, New York
Clinical Trial Site
Charlotte, North Carolina
Clinical Trial Site
Durham, North Carolina
Clinical Trial Site
Cincinnati, Ohio
Clinical Trial Site
Oklahoma City, Oklahoma
Clinical Trial Site
Philadelphia, Pennsylvania
Clinical Trial Site
Charleston, South Carolina
Clinical Trial Site
Austin, Texas
Clinical Trial Site
Dallas, Texas
Clinical Trial Site
Houston, Texas
Clinical Trial Site
Round Rock, Texas
Clinical Trial Site
Winchester, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.